Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world multicenter registry of total flavonoids of Aurantii Fructus for functional dyspepsia (postprandial distress syndrome)
ChiCTR2500102221Phase 4Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Sun Yat-sen University
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Total Flavonoids of Fructus Aurantii Immaturus in functional dyspepsia (FD) (3 arms), sponsored by The First Affiliated Hospital of Sun Yat-sen University. Primary endpoint: Response rate of FD-PDS symptoms after 4 weeks of medication. Planned start May 2025; status: not yet recruiting.
02
Drugs
Total Flavonoids of Fructus Aurantii Immaturus
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on ChiCTR2500102221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102221.